Clinical Trial Update: A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety, tolerability, distribution, and activity of NNC0148-0000-0287 in healthy subjects and in individuals with T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NNC0148-0000-0287

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED